R1 RCM (R1 RCM) Earnings per Share (Diluted) : $0.01 (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is R1 RCM Earnings per Share (Diluted)?

R1 RCM's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.01.

R1 RCM's EPS (Basic) for the three months ended in Dec. 2023 was $0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.01.

R1 RCM's EPS without NRI for the three months ended in Dec. 2023 was $0.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $0.18.

During the past 12 months, R1 RCM's average EPS without NRIGrowth Rate was -25.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -18.70% per year.

During the past 13 years, R1 RCM's highest 3-Year average EPS without NRI Growth Rate was 129.10% per year. The lowest was -64.40% per year. And the median was 2.00% per year.

R1 RCM Earnings per Share (Diluted) Historical Data

The historical data trend for R1 RCM's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R1 RCM Earnings per Share (Diluted) Chart

R1 RCM Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Earnings per Share (Diluted)

Get a 7-Day Free Trial

-0.08

0.32

-1.90

-0.18

0.01

R1 RCM Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Earnings per Share (Diluted)	Get a 7-Day Free Trial															-0.09	-	-	-	0.01

Competitive Comparison of R1 RCM's Earnings per Share (Diluted)

For the Health Information Services subindustry, R1 RCM's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

R1 RCM's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, R1 RCM's PE Ratio distribution charts can be found below:

* The bar in red indicates where R1 RCM's PE Ratio falls into.

R1 RCM Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

R1 RCM's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(3.3	-	0)	/	454.094
	=	0.01

R1 RCM's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(1.4	-	0)	/	451.865
	=	0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

R1 RCM (NAS:RCM) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

R1 RCM Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of R1 RCM's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

R1 RCM (R1 RCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » R1 RCM Inc (NAS:RCM) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

6HL:Germany 6HL0:Germany

Address

434 West Ascension Way, 6th Floor, Murray, UT, USA, 84123

Website

https://www.r1rcm.com

R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.

Executives

Dominic Nakis	director	433 W ASCENSION WAY, SUITE 200, MURRAY UT 84123
Henneman John B Iii	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Evans Richard B. Jr.	officer: Principal Accounting Officer	C/O ACCRETIVE HEALTH, INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
John M. Sparby	officer: See Remarks	C/O R1 RCM INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
Lee Rivas	officer: President	C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Kyle Hicok	officer: Chief Commercial Officer	434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Jennifer D. Williams	officer: Chief Financial Officer	434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Janie Wade	director	C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Tcp-asc Achi Series Lllp	director, 10 percent owner	65 E 55TH ST 27TH FLOOR, TOWERBROOK CAPITAL PARTNERS L.P., NEW YORK NY 10022
Joseph Gerard Flanagan	director, officer: Chief Executive Officer	C/O NORTEL NETWORKS CORPORATION, 195 THE WEST MALL, TORONTO A6 M9C 5K1
Brian K. Dean	director	R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Gary Steven Long	officer: See Remarks	7050 BRIXTON PLACE, SUWANEE GA 30024
Michael C. Feiner	director	1166 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK NY 10036
Matthew S. Holt	director	C/O NEW MOUNTAIN CAPITAL, LLC, 787 SEVENTH AVENUE, 49TH FLOOR, NEW YORK NY 10019
Bradford Kyle Armbrester	director	311 ARSENAL STREET, WATERTOWN MA 02472